临床症状与静脉回流障碍患者超声及体积描记参数的关系
本研究回顾性分析131例(134条肢体)因孤立性静脉回流障碍接受浅静脉腔内激光消融的慢性静脉疾病患者,评估双功能超声和空气体积描记参数与临床参数的关系。发现静脉节段病变评分(VSDS)与静脉临床严重程度评分(VCSS)中度相关,静脉容积(VV)与肿胀分级中度相关;VSDS可预测CEAP临床分级和VCSS,VV可预测肿胀分级;术后VSDS预测VCSS改善,VV和射血分数预测肿胀改善。
要点
- VSDS与VCSS中度相关(r=0.4,P=.004),可预测CEAP分级和VCSS。
- VV与肿胀分级中度相关(r=0.4,P<.001),可预测肿胀分级。
- 术后VSDS预测VCSS改善,VV和EF预测肿胀改善。
核心结论
- 在孤立性静脉回流导致的有症状慢性静脉疾病患者中,初始临床表现和术后改善可由DUS的VSDS及APG的VV和EF预测。
研究设计与样本
- 回顾性分析131例(134条肢体)因症状性慢性静脉疾病静脉回流接受成功浅静脉腔内激光消融(伴或不伴点式剥脱)的患者数据。
主要发现
- DUS参数(GSV直径和总回流容积)与临床参数相关性弱(r=0.1-0.3;P>.05)。
- VSDS与VCSS中度相关(r=0.4;P=.004)。
- APG参数中除VV外与临床参数相关性弱,VV与肿胀分级中度相关(r=0.4;P<.001)。
- 基线VSDS是CEAP临床分级(HR=8.1;P=.005)和VCSS(HR=5.3;P=.03)的显著预测因子,VV是肿胀分级的显著预测因子(HR=17;P<.001)。
- 术后VSDS预测VCSS改善(HR=9.3;P=.003),VV(HR=5.5;P=.02)和EF(HR=6.2;P=.01)预测肿胀改善。
临床怎么用
- 可利用DUS的VSDS和APG的VV、EF辅助预测患者临床表现及术后改善情况。
局限性
- 回顾性研究设计,随访中位时间188天,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although a multitude of techniques exist for the treatment of superficial venous reflux in symptomatic patients with chronic venous disease (CVD), metrics used to determine and quantify superficial reflux and thereby assess the need for intervention remain unclear. This study explores this topic by evaluating duplex ultrasound (DUS) and air plethysmography (APG) metrics in terms of their relation to clinical parameters in the setting of isolated lower extremity venous reflux. METHODS: Analysis of retrospectively collected data of patients who underwent successful endovenous laser ablation of superficial venous reflux with/without stab phlebectomies for symptomatic CVD from venous reflux was carried out to determine predictors of initial clinical presentation and outcomes after successful intervention. Characteristics evaluated included the Clinical, Etiology, Anatomy, and Pathophysiology (CEAP) clinical class, venous clinical severity score (VCSS), grade of swelling (GOS), and visual analog scale pain; DUS characteristics included superficial vein diameter, total reflux volume in the limb, and venous segmental disease score (VSDS). APG metrics included venous volume (VV) and venous filling index, in addition to calf pump function metrics (ejection fraction [EF] and residual volume fraction). Bivariate correlation analysis, paired/unpaired t tests, and regression analysis were used to evaluate the data. RESULTS: There were 131 patients (134 limbs) with a median age of 61 (25-87) years, of whom 96 were women and 35 men. The median body mass index was 28.3 (18-57). There were 44 limbs in the C2 class, 38 limbs in the C3 class, 42 limbs in the C4 class, 2 limbs in the C5 class, and 8 limbs in the C6 class. All limbs had superficial reflux, including 80 with superficial reflux in the great saphenous vein (GSV) alone, and 54 had reflux in both GSV and small saphenous vein (SSV). There were no limbs with isolated reflux in the SSV. A total of 57 limbs had additional reflux in the deep veins (30 axial deep venous reflux). There were 21 limbs with reflux in the perforator veins. All limbs underwent successful ablation of the GSV, whereas 120 underwent additional stab phlebectomies at the same time, 1 limb had additional sclerotherapy (also at the time of the index procedure), and 5 limbs underwent treatment of the SSV. The median follow-up was 188 days. The correlation between DUS metrics (GSV diameter and total reflux volume) and clinical parameters (CEAP clinical class, VCSS, GOS, and visual analog scale pain score) was weak (r = 0.1-0.3; P > .05), although VSDS had a moderate correlation (r = 0.4; P = .004) with VCSS. A weak correlation was also noted between the clinical parameters and APG metrics (venous filling index, EF, residual volume fraction), except VV, which had a moderate correlation (r = 0.4; P < .001). At baseline, while VSDS was found to be a significant predictor for CEAP clinical class (hazard ratio [HR] = 8.1; P = .005) and VCSS (HR = 5.3, P = .03), VV was noted to be a significant predictor for GOS (HR =17; P < .001). After successful superficial venous intervention, there was improvement in clinical, DUS (VSDS), and APG metrics. VSDS was again a significant predictor of improvement in VCSS (HR = 9.3; P = .003), whereas both VV (HR = 5.5, P = .02) and EF (HR = 6.2; P = .01) were significant predictors for improvement in GOS after intervention. CONCLUSIONS: In symptomatic patients with CVD from isolated venous reflux, initial clinical presentation and improvement after successful superficial venous intervention can be predicted by DUS (VSDS) and APG (VV and EF) metrics. After such intervention, there is improvement in clinical, DUS, and APG metrics.
引用
- Jayaraj A, Owens J, Dickerson MM, et al. Relation between clinical findings and diagnostic parameters in patients undergoing superficial venous intervention for symptomatic chronic venous disease due to isolated venous reflux. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 41519469. doi:10.1016/j.jvsv.2026.102445
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。